Non-invasive decision support for NSCLC treatment using PET/CT radiomics
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-invasive decision support for NSCLC treatment using PET/CT radiomics
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-16
DOI
10.1038/s41467-020-19116-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predicting EGFR Mutation Status in Lung Adenocarcinoma on CT Image Using Deep Learning
- (2019) Shuo Wang et al. EUROPEAN RESPIRATORY JOURNAL
- Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma
- (2019) Hao Peng et al. CLINICAL CANCER RESEARCH
- EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
- (2019) K Hastings et al. ANNALS OF ONCOLOGY
- Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis
- (2019) Alexandra Giatromanolaki et al. MEDICAL ONCOLOGY
- Mathematical Modeling of Pre-Clinical Alpha-Emitter Radiopharmaceutical Therapy
- (2019) Alireza Karimian et al. CANCER RESEARCH
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- A PET imaging approach for determining EGFR mutation status for improved lung cancer patient management
- (2018) Xilin Sun et al. Science Translational Medicine
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
- (2018) Yannick Simoni et al. NATURE
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Radiomics: the bridge between medical imaging and personalized medicine
- (2017) Philippe Lambin et al. Nature Reviews Clinical Oncology
- Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)
- (2016) J. M. Kim et al. ANNALS OF ONCOLOGY
- EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis
- (2016) J. F. Gainor et al. CLINICAL CANCER RESEARCH
- Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas
- (2016) Ying Liu et al. Clinical Lung Cancer
- Associations Between Somatic Mutations and Metabolic Imaging Phenotypes in Non–Small Cell Lung Cancer
- (2016) Stephen S.F. Yip et al. JOURNAL OF NUCLEAR MEDICINE
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma
- (2016) Ying Liu et al. RADIOLOGY
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
- (2014) Carlos Caicedo et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Influence of Chemotherapy onEGFRMutation Status Among Patients With Non–Small-Cell Lung Cancer
- (2012) Hua Bai et al. JOURNAL OF CLINICAL ONCOLOGY
- EGFRmutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples
- (2012) Gillian Ellison et al. JOURNAL OF CLINICAL PATHOLOGY
- Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Predicting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer
- (2011) R. H. Mak et al. ONCOLOGIST
- 18F-FDG uptake and EGFR mutations in patients with non-small cell lung cancer: A single-institution retrospective analysis
- (2009) Im Il Na et al. LUNG CANCER
- Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib
- (2008) Kazuya Taniguchi et al. CANCER SCIENCE
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More